Abstract
The proto-oncogene c-kit and its ligand stemcell factor (SCF) may play an important role in the development of normal and malignant testicular tissue. This study investigates the presence of SCF and c-kit protein in 32 orchiectomy specimens of patients with testicular cancer, in 5 specimens of normal testicular tissue and in three established non-seminomatous germ-cell cancer cell lines (H12.1, H32, 577ML) by an immunohistochemical approach. Out of 9 testicular cancer specimens classified as pure seminomas, 7 (78%) showed a strong immunohistochemical reaction for both SCF and c-kit protein on the surface of the tumour cells. Fourteen non-seminomatous germ-cell tumours composed of embryonal carcinoma were completely negative for both SCF and c-kit protein and only faint positivity was found in 6 tumours (26%). Differentiated teratomatous structures within the specimens of nonseminomatous tumours showed a strong immunohistochemical reaction for SCF and c-kit protein in 8 of 11 (73%) cases. All three testicular cancer cell lines showed only faint staining reactions for c-kit protein and none for SCF. No secretion of SCF by the three lines in vitro was detected. The addition of high concentrations of SCF (100 ng/ml) to the testicular cancer cell lines in culture conditions without fetal calf serum resulted in a 1.4 to 3-fold growth stimulation compared to cell growth in serum-free medium alone. This effect was not detectable when the cells were cultured in serum-containing media. In the normal testicular tissue the germ-cells displayed a strong immunohistochemical reaction for c-kit protein while SCF positivity was found at the tubular membrane and on the surface of Sertoli cells. The SCF/c-kit system may possess a regulatory function in normal testicular tissue by possibly providing the microenvironment necessary for spermatogenesis. With the development of testicular cancer, this regulatory system seems to be lost, particularly in non-seminomatous germ-cell tumours. A growthstimulatory effect of high concentrations of SCF on nonseminomatous testicular cancer cell lines can be detected only in culture conditions with serum-free media. The effects achievable by the combination of SCF with other growth factors need to be further studied, as well as the role of the c-kit/SCF regulatory system for normal spermatogenesis and its possible implications for the understanding and treatment of male infertility.
Key words: Testicular cancer, Spermatogenesis, Stem-cell factor (SCF), c-kit proto-oncogene, Growth stimulation
References
- Bokemeyer C, Dunn T, Harstrick A, Lerch T, Poliwoda H, Schmoll HJ (1994) Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents. Int J Cancer 56: 452–456 [DOI] [PubMed] [Google Scholar]
- Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RSK (1994) Clinical relevance of the i(12p) marker chromosome in germ-cell tumors. J Natl Cancer Inst 86: 349–355 [DOI] [PubMed] [Google Scholar]
- Casper J, Schmoll HJ, Schnaidt U, Fonatsch C (1987) Cell lines of human germinal cancer. Int J Androl 10: 105–113 [DOI] [PubMed] [Google Scholar]
- Geissler EN, Ryan MA, Housman DE (1988) The dominant whitespotting (w) locus of the mouse encodes the c-kit proto-oncogene. Cell 55: 185–192 [DOI] [PubMed] [Google Scholar]
- Gibas Z, Prout GRJ, Sandberg AA (1984) Malignant teratoma of the testis with an isochromosome no 12, i(12p), as the sole structural cytogenetic abnormality. J Urol 131: 762 [DOI] [PubMed] [Google Scholar]
- Godin I, Deed R, Cooke J, Zsebo K, Dexter M, Wylie C (1991) Effects of the steel gene product on mouse primordial germ-cells in culture. Nature 352: 807–809 [DOI] [PubMed] [Google Scholar]
- Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G (1994) Coexpression of the c-kit receptor and the stem-cell factor in gynecological tumors. Cancer Res 54: 3049–3053 [PubMed] [Google Scholar]
- Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T, Suguira T, Ariyoshi Y, Ueda R (1993) Expression for the c-kit protein in human solid tumours and in corresponding fetal and adult normal tissues. Am J Pathol 142: 339–346 [PMC free article] [PubMed] [Google Scholar]
- Murty V, Houldsworth J, Baldwin S, Reuter V, Hunziker W, Besmer P, Bosl G, Chaganti R (1992) Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ-cell tumors. Proc Natl Acad Sci USA 89: 11006–11010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Natali PG, Nicotra MR, Sures I, Mottolese M, Botti C, Ullrich A (1992) Breast cancer is associated with loss of the c-kit oncogene product. Int J Cancer 52: 713–717 [DOI] [PubMed] [Google Scholar]
- Pietsch T, Kyas U, Steffens U, Yakisan E, Hadam MR, Ludwig WD, Zsebo K, Welte K (1992) Effects of human stem-cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogenity in response and synergy with other hematopoietic growth factors. Blood 80: 1199–1205 [PubMed] [Google Scholar]
- Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl G, Chaganti R (1992) Cytogenetic analysis of 124 prospectively ascertained male germ-cell tumors. Cancer Res 52: 2285–2291 [PubMed] [Google Scholar]
- Rossi P, Dolci S, Grimaldi P, Ricca R, Geremia R (1993) Folliclestimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulating of DNA synthesis in spermatogonia by soluble SLF. Dev Biol 155: 68–74 [DOI] [PubMed] [Google Scholar]
- Sekido Y, Obata Y, Ueda R, Hida T, Suyama M, Shimakata K, Ariyoshi Y, Takahashi T (1991) Preferential expression of c-kit protooncogene transcripts in small-cell lung cancer. Cancer Res 51: 2416–2419 [PubMed] [Google Scholar]
- Skeehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 82: 1107–1112 [DOI] [PubMed] [Google Scholar]
- Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of theHER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712 [DOI] [PubMed] [Google Scholar]
- Strohmeyer T, Slamon DJ (1994) Proto-oncogenes and tumor suppressor genes in human urological malignancies. J Urol 151: 1479–1497 [DOI] [PubMed] [Google Scholar]
- Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon D (1991) Expression of thehst-1 and c-kit protooncogenes in human testicular germ-cell tumours. Cancer Res 51: 1811–1816 [PubMed] [Google Scholar]
- Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M, Slamon D (1995) Expression of the c-kit proto-oncogene and its ligand stem-cell factor (SCF)' in normal and malignant human testicular tissue. J Urol 153: 511–515 [DOI] [PubMed] [Google Scholar]
- Tan JC, Nocka K, Ray P, Traktman P, Besmer P (1990) The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247: 209–212 [DOI] [PubMed] [Google Scholar]
- Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC (1992) Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80: 374–381 [PubMed] [Google Scholar]
- Wang N, Trend B, Bronson D, Fraley EE (1980) Non-random abnormalities in chromosome 1 in human testicular cancers. Cancer Res 40: 796–802 [PubMed] [Google Scholar]
- Witte ON (1990) Steel locus defines new multipotent growth factor. Cell 63: 5–6 [DOI] [PubMed] [Google Scholar]
- Yarden Y, Kuang WS, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessingen J, Francke U, Ullrich A (1987) Human proto-oncogene c-kit, a new cell-surface-receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341–3351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett N C, Okino KH, Murdock DC, Jacobsen FW, Galli SJ, Suggs, SV (1990) Stem cell factor is encoded at the s/locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213–224 [DOI] [PubMed] [Google Scholar]
